Posted by admin on Aug 6th, 2022

BioLife Solutions (NASDAQ:BLFS – Get Rating) and Electromed (NYSE:ELMD – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, profitability, dividends, risk and earnings.

83.5% of BioLife Solutions shares are held by institutional investors. Comparatively, 32.7% of Electromed shares are held by institutional investors. 5.9% of BioLife Solutions shares are held by insiders. Comparatively, 26.7% of Electromed shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

This table compares BioLife Solutions and Electromed’s top-line revenue, earnings per share and valuation.

Electromed has lower revenue, but higher earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

BioLife Solutions has a beta of 1.99, indicating that its share price is 99% more volatile than the S&P 500. Comparatively, Electromed has a beta of 0.59, indicating that its share price is 41% less volatile than the S&P 500.

This is a breakdown of current ratings and price targets for BioLife Solutions and Electromed, as reported by MarketBeat.

BioLife Solutions presently has a consensus target price of $42.17, suggesting a potential upside of 96.22%. Electromed has a consensus target price of $20.00, suggesting a potential upside of 116.22%. Given Electromed’s higher probable upside, analysts clearly believe Electromed is more favorable than BioLife Solutions.

This table compares BioLife Solutions and Electromed’s net margins, return on equity and return on assets.

Electromed beats BioLife Solutions on 8 of the 13 factors compared between the two stocks.

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.

Viant Technology Inc. (NASDAQ:DSP) Receives $14.00 Consensus Target Price from Analysts

Robert W. Baird Increases BorgWarner (NYSE:BWA) Price Target to $44.00